Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Cipla
Accenture
Fuji
Fish and Richardson
Harvard Business School

Generated: August 22, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017672

  Try a free trial


See Plans and Pricing

« Back to Dashboard

NDA 017672 describes LITHONATE, which is a drug marketed by Solvay and is included in two NDAs. Additional details are available on the LITHONATE profile page.

The generic ingredient in LITHONATE is lithium citrate. There are fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the lithium citrate profile page.
Summary for 017672
Tradename:LITHONATE
Applicant:Solvay
Ingredient:lithium citrate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SYRUP;ORALStrengthEQ 300MG CARBONATE/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
US Army
Covington
McKesson
Healthtrust
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.